Announced new data demonstrating a unique mechanism of action supporting the best-in-class potential of rademikibart –– Recruitment ongoing for ...

As is my tradition, I planned on giving a hilarious recap of all the political, social, and of course, health news that happened in 2025. However, two things happened.One is a personal lack of ...

The diagnosis and management of invasive fungal infections in adult patients with hematological malignancies remains a ...

Dual anti-platelet therapy remains a cornerstone of the treatment for coronary artery disease. When choosing a second anti-platelet, ticagrelor remains a principal agent after the recent PLATO trial ...